Opioid Executive Who Gave Up $5 Million Points Finger at Insys Founder
- Ex-head of marketing describes methods at racketeering trial
- Disagreement with Insys’s founder led to a shouting match
Photographer: Craig F. Walker/The Boston Globe via Getty Images
This article is for subscribers only.
Insys Therapeutics Inc. founder John Kapoor promoted a policy that pushed doctors to prescribe higher doses of the company’s opioid drug to boost profits, a former marketing manager told a Boston jury at the former CEO’s racketeering trial.
Matthew Napoletano, Insys’s former head of marketing, said he objected repeatedly to his boss’s methods, but was assured they wouldn’t get him in trouble. He eventually quit, giving up $5 million to $7 million in stock options, he said.